Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Cogn Behav Neurol ; 25(3): 128-38, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22960437

ABSTRACT

OBJECTIVES/BACKGROUND: Ecstasy/polydrug users have exhibited deficits in executive functioning in laboratory tests. We sought to extend these findings by investigating the extent to which ecstasy/polydrug users manifest executive deficits in everyday life. METHODS: Forty-two current ecstasy/polydrug users, 18 previous (abstinent for at least 6 months) ecstasy/polydrug users, and 50 non-users of ecstasy (including both non-users of any illicit drug and some cannabis-only users) completed the self-report Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A) measure. RESULTS: Current ecstasy/polydrug users performed significantly worse than previous users and non-users on subscales measuring inhibition, self-monitoring, initiating action, working memory, planning, monitoring ongoing task performance, and organizational ability. Previous ecstasy/polydrug users did not differ significantly from non-users. In regression analyses, although the current frequency of ecstasy use accounted for statistically significant unique variance on 3 of the 9 BRIEF-A subscales, daily cigarette consumption was the main predictor in 6 of the subscales. CONCLUSIONS: Current ecstasy/polydrug users report more executive dysfunction than do previous users and non-users. This finding appears to relate to some aspect of ongoing ecstasy use and seems largely unrelated to the use of other illicit drugs. An unexpected finding was the association of current nicotine consumption with executive dysfunction.


Subject(s)
Cognition Disorders/diagnosis , Drug Users/psychology , Executive Function/drug effects , N-Methyl-3,4-methylenedioxyamphetamine/pharmacology , Adolescent , Adult , Cognition Disorders/psychology , Diagnostic Self Evaluation , Female , Humans , Male , Memory/drug effects , Neuropsychological Tests , Self Report , Substance-Related Disorders/psychology , Surveys and Questionnaires
2.
Psychopharmacology (Berl) ; 215(4): 761-74, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21301817

ABSTRACT

RATIONALE: Prospective memory (PM) deficits in recreational drug users have been documented in recent years. However, the assessment of PM has largely been restricted to self-reported measures that fail to capture the distinction between event-based and time-based PM. The aim of the present study is to address this limitation. OBJECTIVES: Extending our previous research, we augmented the range laboratory measures of PM by employing the CAMPROMPT test battery to investigate the impact of illicit drug use on prospective remembering in a sample of cannabis only, ecstasy/polydrug and non-users of illicit drugs, separating event and time-based PM performance. We also administered measures of executive function and retrospective memory in order to establish whether ecstasy/polydrug deficits in PM were mediated by group differences in these processes. RESULTS: Ecstasy/polydrug users performed significantly worse on both event and time-based prospective memory tasks in comparison to both cannabis only and non-user groups. Furthermore, it was found that across the whole sample, better retrospective memory and executive functioning was associated with superior PM performance. Nevertheless, this association did not mediate the drug-related effects that were observed. Consistent with our previous study, recreational use of cocaine was linked to PM deficits. CONCLUSIONS: PM deficits have again been found among ecstasy/polydrug users, which appear to be unrelated to group differences in executive function and retrospective memory. However, the possibility that these are attributable to cocaine use cannot be excluded.


Subject(s)
Memory Disorders/psychology , Memory/drug effects , N-Methyl-3,4-methylenedioxyamphetamine/adverse effects , Substance-Related Disorders/psychology , Amphetamine-Related Disorders/psychology , Cannabis/adverse effects , Case-Control Studies , Female , Humans , Male , Marijuana Abuse/psychology , Memory/physiology , Memory Disorders/chemically induced , Memory, Long-Term/drug effects , Memory, Long-Term/physiology , Psychological Tests , Retention, Psychology/drug effects , Retention, Psychology/physiology , Surveys and Questionnaires
3.
J Psychopharmacol ; 25(4): 453-64, 2011 Apr.
Article in English | MEDLINE | ID: mdl-20123936

ABSTRACT

The impact of ecstasy/polydrug use on real-world memory (i.e. everyday memory, cognitive failures and prospective memory [PM]) was investigated in a sample of 42 ecstasy/polydrug users and 31 non-ecstasy users. Laboratory-based PM tasks were administered along with self-reported measures of PM to test whether any ecstasy/polydrug-related impairment on the different aspects of PM was present. Self-reported measures of everyday memory and cognitive failures were also administered. Ecstasy/polydrug associated deficits were observed on both laboratory and self-reported measures of PM and everyday memory. The present study extends previous research by demonstrating that deficits in PM are real and cannot be simply attributed to self-misperceptions. The deficits observed reflect some general capacity underpinning both time- and event-based PM contexts and are not task specific. Among this group of ecstasy/polydrug users recreational use of cocaine was also prominently associated with PM deficits. Further research might explore the differential effects of individual illicit drugs on real-world memory.


Subject(s)
Cognition Disorders/chemically induced , Illicit Drugs/adverse effects , Memory Disorders/chemically induced , Memory/drug effects , N-Methyl-3,4-methylenedioxyamphetamine/adverse effects , Serotonin Agents/adverse effects , Substance-Related Disorders/psychology , Cognition/drug effects , Comprehension/drug effects , Female , Humans , Male , Mental Recall/drug effects , N-Methyl-3,4-methylenedioxyamphetamine/pharmacology , Neuropsychological Tests , Self Concept , Serotonin Agents/pharmacology , Substance-Related Disorders/pathology , Time Factors
4.
Behav Brain Res ; 216(1): 285-92, 2011 Jan 01.
Article in English | MEDLINE | ID: mdl-20723567

ABSTRACT

Neurokinin-1, (NK1) receptor antagonists offer strong potential as anxiolytic drugs with few side effects. The use of the Mongolian gerbil for anxiety research offers advantages because gerbil NK1 receptors share a greater homology with human NK1 receptors than those of other rodents. Studies are needed to validate existing tests of anxiety for use with this species. This study examined the effects of two anxiolytics (buspirone and diazepam) and two anxiogenics (caffeine and FG142) on male and female gerbil behaviour in the black-white box (BWB). Diazepam was anxiolytic in males but not females. The anxiolytic effects of buspirone were apparent at the lower doses in both males and females. Higher doses resulted in sedative effects in both sexes. Caffeine produced mild anxiogenesis in females at the lowest dose, and in males at the highest dose. FG7142 was mildly anxiogenic in males and not at all in females. Findings are discussed in light of previous research. The gerbil BWB should not be used as a valid test of anxiety in its current form.


Subject(s)
Anxiety/chemically induced , Anxiety/drug therapy , Behavior, Animal/drug effects , Buspirone/pharmacology , Caffeine/pharmacology , Carbolines/pharmacology , Diazepam/pharmacology , Animals , Anti-Anxiety Agents/pharmacology , Anti-Anxiety Agents/therapeutic use , Buspirone/therapeutic use , Central Nervous System Stimulants/pharmacology , Diazepam/therapeutic use , Dose-Response Relationship, Drug , Female , GABA Antagonists/pharmacology , Gerbillinae , Male , Sex Factors
5.
Behav Brain Res ; 207(2): 490-9, 2010 Mar 05.
Article in English | MEDLINE | ID: mdl-19891994

ABSTRACT

Progesterone generally produces anxiolytic effects in rats and mice. However, sex differences in response to this neuroactive steroid have not been systematically investigated. Thus, this study investigated the anxiety-modulating actions of acute, chronic and withdrawn progesterone treatment in male and female Mongolian gerbils (Meriones unguiculatus) in the elevated plus-maze (EPM) and black-white box (BWB). Gerbils were tested after receiving vehicle, 0.5, 2.5, 7.5 or 15 mg/kg progesterone administered acutely, chronically (14 days) or after a 24-h withdrawal period following chronic treatment. Data analyses showed that overall the effects of progesterone were similar in males and females. Progesterone produced few behavioural alterations in the EPM following any of the treatment regimes. However, acute and chronic progesterone reduced anxiety in the BWB (as shown by increased exploration, locomotion and entries into the white compartment). In contrast, withdrawal of progesterone produced minimal effects in the EPM and BWB. This study suggests that the BWB maybe the most suitable test for detecting the anxiolytic effects of neuroactive steroids in gerbils. However, further research is needed to clarify the behavioural effects of progesterone in this species.


Subject(s)
Anti-Anxiety Agents/pharmacology , Anxiety/drug therapy , Progesterone/pharmacology , Analysis of Variance , Animals , Anti-Anxiety Agents/administration & dosage , Exploratory Behavior/drug effects , Female , Gerbillinae , Male , Motor Activity/drug effects , Neuropsychological Tests , Progesterone/administration & dosage , Random Allocation , Sex Characteristics , Substance Withdrawal Syndrome , Time Factors
6.
Acta Neurobiol Exp (Wars) ; 68(2): 131-8, 2008.
Article in English | MEDLINE | ID: mdl-18511949

ABSTRACT

Chronic stress an/or glucocorticoid administration produces atrophy of hippocampal neurons. However, evidence of the impact of glucocorticoids on glial cells, especially in both males and females, is limited. In the present study, we investigated the total percentage body weight, hippocampal volume and hippocampal astrocyte numbers following chronic corticosterone treatment in male and female Wistar rats. Males had greater left and right hippocampal volumes overall, but no effect on hippocampal volume was seen after corticosterone treatment. Total body weight was dose-dependently lower in both sexes, but the decrease was more prominent in male rats. Corticosterone treatment dose-dependently increased astrocyte numbers in the CA1 region, but not in the lateral and medial CA3 hippocampal regions. This increase was similar in both male and female rats. The astrogliosis observed following chronic corticosterone may have implications for extrasynaptic communication and neuron-glia interactions and is similar to changes in the astrocytic population observed in aged rats.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Astrocytes/drug effects , Corticosterone/pharmacology , Hippocampus/cytology , Sex Characteristics , Analysis of Variance , Animals , Body Weight/drug effects , Cell Count/methods , Dose-Response Relationship, Drug , Drug Administration Schedule , Female , Hippocampus/drug effects , Male , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...